Many low-abundance mutations lie below the sensitivity and selectivity of molecular assays and, as such, limit the accuracy of the assay analysis; such scenarios make it especially difficult to ...
Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the “Company”, an emerging leader in age-reversal science, today announced significant findings from its copper binding studies with Telomir-1. This is ...